A novel, water-resistant patch-wearable cardioverter-defibrillator (P-WCD) is safe and effective for patients at risk for sudden cardiac arrest, according to a study published in the Aug. 6 issue of ...

Please provide your email address to receive an email when new articles are posted on . A novel adhesive-based wearable cardioverter defibrillator exceeded its safety and efficacy performance goals.

About 7000 implantable cardioverter-defibrillators are implanted annually in Canada to prevent sudden death.1 However, patient preferences may change, and goals of care may shift to improving quality ...

The Interventional Procedures Advisory Committee has considered this procedure and NICE has now issued a consultation document about its safety and efficacy. This has been issued for four weeks’ ...

Exercise plays an important role in rehabilitation after implantation of a pacemaker or other cardioverter defibrillator because it will counteract the deconditioning that occurred prior to ...

The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...

Sudden death from cardiac causes remains a leading cause of death among patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable cardioverter–defibrillator (ICD) has ...

A Wolverhampton patient has become one of the first in the country to receive a new type of implantable ...

Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...

An entirely subcutaneous implantable cardioverter defibrillator (ICD) differs from a transvenous ICD in that a single lead is placed subcutaneously. This single lead comprises 2 sensing ring ...